Xtant Medical Holdings Stock Net Income
XTNT Stock | USD 1.11 0.05 4.72% |
Xtant Medical Holdings fundamentals help investors to digest information that contributes to Xtant Medical's financial success or failures. It also enables traders to predict the movement of Xtant Stock. The fundamental analysis module provides a way to measure Xtant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xtant Medical stock.
At this time, Xtant Medical's Net Income is comparatively stable compared to the past year. Net Income From Continuing Ops is likely to gain to about 2.9 M in 2024, whereas Net Loss is likely to drop (10.2 M) in 2024. Xtant | Net Income |
Xtant Net Income Analysis
Xtant Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
More About Net Income | All Equity Analysis
Xtant Medical Net Income |
|
Net Income | = | (Rev + Gain) | - | (Exp + Loss) |
Current Xtant Medical Net Income | 2.75 M |
Most of Xtant Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xtant Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Xtant Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Xtant Medical Holdings reported net income of 2.75 M. This is 99.19% lower than that of the Health Care Equipment & Supplies sector and 98.84% lower than that of the Health Care industry. The net income for all United States stocks is 99.52% higher than that of the company.
Xtant Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xtant Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics of similar companies.Xtant Medical is currently under evaluation in net income category among related companies.
Xtant Fundamentals
Return On Equity | 0.063 | ||||
Return On Asset | -0.0682 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 152.28 M | ||||
Shares Outstanding | 130.11 M | ||||
Shares Owned By Insiders | 7.19 % | ||||
Shares Owned By Institutions | 69.32 % | ||||
Number Of Shares Shorted | 172.81 K | ||||
Price To Earning | (0.41) X | ||||
Price To Book | 2.52 X | ||||
Price To Sales | 1.85 X | ||||
Revenue | 78.47 M | ||||
Gross Profit | 32.14 M | ||||
EBITDA | (5.6 M) | ||||
Net Income | 2.75 M | ||||
Cash And Equivalents | 16.5 M | ||||
Cash Per Share | 0.19 X | ||||
Total Debt | 17.07 M | ||||
Debt To Equity | 0.60 % | ||||
Current Ratio | 3.57 X | ||||
Book Value Per Share | 0.42 X | ||||
Cash Flow From Operations | (10.89 M) | ||||
Short Ratio | 2.11 X | ||||
Earnings Per Share | 0.02 X | ||||
Price To Earnings To Growth | (0.03) X | ||||
Target Price | 1.93 | ||||
Number Of Employees | 134 | ||||
Beta | 0.2 | ||||
Market Capitalization | 145.07 M | ||||
Total Asset | 60.23 M | ||||
Retained Earnings | (243.67 M) | ||||
Working Capital | 34.1 M | ||||
Current Asset | 45.04 M | ||||
Current Liabilities | 21.47 M | ||||
Z Score | 1.11 | ||||
Net Asset | 60.23 M |
About Xtant Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xtant Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Net Income | 2.8 M | 2.9 M | |
Net Income From Continuing Ops | 2.8 M | 2.9 M | |
Net Loss | -9.8 M | -10.2 M | |
Net Income Per E B T | 0.91 | 0.72 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out Xtant Medical Piotroski F Score and Xtant Medical Altman Z Score analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Xtant Stock analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Xtant Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 0.69 | Quarterly Revenue Growth 0.73 | Return On Assets (0.07) | Return On Equity 0.063 |
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.